<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nakayasu ES</submitter><funding>NIDDK NIH HHS</funding><pagination>100725</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12807541</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(4)</volume><pubmed_abstract>There are an estimated 3.7 million people with undiagnosed type 1 diabetes (T1D), living primarily in poor areas of the globe. Therefore, there is a need for non-invasive, affordable tests to provide accurate diagnosis despite the time post-disease onset and fasting state. Here, we studied persistent urinary T1D biomarkers that can be used to develop such tests. We analyzed the urine metabolomes of three independent cohorts of samples collected within 48 h (from Indiana University), and 1 year (from University of Colorado) and 1-10 years (6 years in average) (from Children's National Medical Center) post-diagnosis. Samples were submitted to gas chromatography-mass spectrometry and machine learning analyses to determine diagnostic metabolite panels. The data were also mapped into a metaboli</pubmed_abstract><journal>Next research</journal><pubmed_title>Persistent urinary metabolic signatures in children with type 1 diabetes.</pubmed_title><pmcid>PMC12807541</pmcid><funding_grant_id>UC4 DK104166</funding_grant_id><funding_grant_id>K12 DK094712</funding_grant_id><funding_grant_id>R21 DK119800</funding_grant_id><funding_grant_id>DP3 DK094343</funding_grant_id><funding_grant_id>P30 DK097512</funding_grant_id><funding_grant_id>R01 DK138335</funding_grant_id><funding_grant_id>R01 DK093954</funding_grant_id><pubmed_authors>Zink EM</pubmed_authors><pubmed_authors>Nakayasu ES</pubmed_authors><pubmed_authors>Chin J</pubmed_authors><pubmed_authors>Metz TO</pubmed_authors><pubmed_authors>Frohnert BI</pubmed_authors><pubmed_authors>Kim YM</pubmed_authors><pubmed_authors>Flores JE</pubmed_authors><pubmed_authors>Syed F</pubmed_authors><pubmed_authors>Bramer LM</pubmed_authors><pubmed_authors>Evans-Molina C</pubmed_authors><pubmed_authors>Cogen FE</pubmed_authors><pubmed_authors>Pieper R</pubmed_authors><pubmed_authors>Webb-Robertson BM</pubmed_authors><pubmed_authors>Kaplowitz PB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Persistent urinary metabolic signatures in children with type 1 diabetes.</name><description>There are an estimated 3.7 million people with undiagnosed type 1 diabetes (T1D), living primarily in poor areas of the globe. Therefore, there is a need for non-invasive, affordable tests to provide accurate diagnosis despite the time post-disease onset and fasting state. Here, we studied persistent urinary T1D biomarkers that can be used to develop such tests. We analyzed the urine metabolomes of three independent cohorts of samples collected within 48 h (from Indiana University), and 1 year (from University of Colorado) and 1-10 years (6 years in average) (from Children's National Medical Center) post-diagnosis. Samples were submitted to gas chromatography-mass spectrometry and machine learning analyses to determine diagnostic metabolite panels. The data were also mapped into a metaboli</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-05-31T03:17:02.42Z</modification><creation>2026-05-31T03:10:19.081Z</creation></dates><accession>S-EPMC12807541</accession><cross_references><pubmed>41551374</pubmed><doi>10.1016/j.nexres.2025.100725</doi></cross_references></HashMap>